000 03659nam a22004575i 4500
001 60593
005 20200226102504.0
007 cr nn 008mamaa
008 170127s2017 si | s |||| 0|eng d
020 _a9789811020025
_9978-981-10-2002-5
024 7 _a10.1007/978-981-10-2002-5
_2doi
035 _a(DE-He213)978-981-10-2002-5
050 4 _aRC705-779
072 7 _aMJL
_2bicssc
072 7 _aMED079000
_2bisacsh
082 0 4 _a616.2
_223
245 1 0 _aMolecular Targeted Therapy of Lung Cancer
_h[electronic resource] /
_cedited by Yuichi Takiguchi.
264 1 _aSingapore :
_bSpringer Singapore :
_bImprint: Springer,
_c2017.
300 _aX, 327 p. 54 illus., 48 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aPart I Diagnosis -- 1 Classification of adenocarcinoma of the lung - with a special reference to prognosis -- 2 Screening lung cancer with low dose CT combined with molecular markers -- 3 PET-CT, bio-imaging for predicting prognosis and response to chemotherapy in patients with lung cancer -- 4 Methods in molecular diagnosis -- 5 Accurate nodal staging and biomarker testing with endobronchial ultrasound-guided transbronchial needle aspiration -- 6 Next generation sequencing and bioinformatics -- 7 Companion Diagnostics -- Part II Treatment -- 8 Small cell lung cancer and molecular targeted therapy -- 9 Locally advanced non-small cell lung cancer and molecular targeted therapy -- 10 EGFR mutant -- 11 ALK mutant -- 12 Minor-driver mutant -- 13 Mechanism of resistance to targeted molecular therapy -- 14 Immunotherapy -- 15 Lung cancer complicated with interstitial lung diseases -- 16 Management of adverse effects by molecular targeted therapy and immunotherapy -- Part III Evaluation -- 17 Health related-quality of life in molecular targeted therapy -- 18 Gene signature -- Part IV Novel approach -- 19 Targeting epithelial-mesenchymal transition and cancer stem cell- 20 Targeting the Lung Cancer Microenvironment: Harnessing Host Responses.
520 _aThis book discusses the latest molecular targeted therapy of lung cancer including its evaluation and future directions. It clearly illustrates the initial dramatic effectiveness of molecular targeted therapy, recurrence of the disease, overcoming the wide variety of resistance mechanisms using new-generation molecular targeted agents and potential novel approaches. It also outlines the increasing necessity for new diagnostic technology and strategies for managing different adverse effects and novel methods for evaluating effectiveness and safety. Edited and authored by opinion leaders, Molecular Targeted Therapy of Lung Cancer provides a comprehensive overview of the disease and its treatments. It is a valuable resource for graduate students, post-doctoral fellows and faculty staff, as well as researchers involved in clinical and translational research on lung cancer, helping promote new ideas for further advances.
650 0 _aMedicine.
650 0 _aMolecular biology.
650 0 _aRespiratory organs
_xDiseases.
650 0 _aOncology.
650 1 4 _aMedicine & Public Health.
650 2 4 _aPneumology/Respiratory System.
650 2 4 _aOncology.
650 2 4 _aMolecular Medicine.
700 1 _aTakiguchi, Yuichi.
_eeditor.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9789811020001
856 4 0 _uhttp://dx.doi.org/10.1007/978-981-10-2002-5
912 _aZDB-2-SME
999 _c5464
_d5464